| 1 | EXEL | Exelixis, Inc. | 5.25% |
| 2 | COR | Cencora, Inc. | 4.58% |
| 3 | BSX | Boston Scientific Corporation | 4.09% |
| 4 | LLY | Eli Lilly and Company | 3.81% |
| 5 | RMD | ResMed Inc. | 3.75% |
| 6 | AXSM | Axsome Therapeutics, Inc. | 3.46% |
| 7 | BBIO | BridgeBio Pharma, Inc. | 3.36% |
| 8 | TGTX | TG Therapeutics, Inc. | 3.32% |
| 9 | MMSI | Merit Medical Systems, Inc. | 3.28% |
| 10 | ALHC | Alignment Healthcare, Inc. | 3.25% |
| 11 | INSM | Insmed Incorporated | 3.24% |
| 12 | GH | Guardant Health, Inc. | 3.24% |
| 13 | ABBV | AbbVie Inc. | 3.19% |
| 14 | MDGL | Madrigal Pharmaceuticals, Inc. | 3.14% |
| 15 | PTGX | Protagonist Therapeutics, Inc. | 2.89% |
| 16 | LQDA | Liquidia Corporation | 2.82% |
| 17 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.80% |
| 18 | KRYS | Krystal Biotech, Inc. | 2.78% |
| 19 | TRVI | Trevi Therapeutics, Inc. | 2.69% |
| 20 | QURE | uniQure N.V. | 2.54% |
| 21 | PTCT | PTC Therapeutics, Inc. | 2.53% |
| 22 | MASI | Masimo Corporation | 2.52% |
| 23 | AMRX | Amneal Pharmaceuticals, Inc. | 2.49% |
| 24 | MASS | 908 Devices Inc. | 2.45% |
| 25 | ARQT | Arcutis Biotherapeutics, Inc. | 2.43% |
| View PTH holdings |